Tolerogenic vaccines: Targeting the antigenic and cytokine niches of FOXP3+regulatory T cells

被引:10
|
作者
Mannie, Mark D. [1 ]
DeOca, Kayla B. [1 ]
Bastian, Alexander G. [1 ]
Moorman, Cody D. [1 ]
机构
[1] East Carolina Univ, Brody Sch Med, Dept Microbiol & Immunol, 600 Moye Blvd, Greenville, NC 27834 USA
关键词
FOXP3(+) Tregs; Immunological tolerance; T cell antigen receptor; Tolerogenic vaccination; Clonotypic specificity; MYELIN BASIC-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; DENDRITIC CELLS; GM-CSF; INFECTIOUS TOLERANCE; REGULATORY CELLS; IL-2; RECEPTOR; SELF-ANTIGEN; REFRACTORY PHASE;
D O I
10.1016/j.cellimm.2020.104173
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
FOXP3(+) regulatory T cells (Tregs) constitute a critical barrier that enforces tolerance to both the self-peptidome and the extended-self peptidome to ensure tissue-specific resistance to autoimmune, allergic, and other inflammatory disorders. Here, we review intuitive models regarding how T cell antigen receptor (TCR) specificity and antigen recognition efficiency shape the Treg and conventional T cell (Tcon) repertoires to adaptively regulate T cell maintenance, tissue-residency, phenotypic stability, and immune function in peripheral tissues. Three zones of TCR recognition efficiency are considered, including Tcon recognition of specific low-efficiency self MHC-ligands, Treg recognition of intermediate-efficiency agonistic self MHC-ligands, and Tcon recognition of cross-reactive high-efficiency agonistic foreign MHC-ligands. These respective zones of TCR recognition efficiency are key to understanding how tissue-resident immune networks integrate the antigenic complexity of local environments to provide adaptive decisions setting the balance of suppressive and immunogenic responses. Importantly, deficiencies in the Treg repertoire appear to be an important cause of chronic inflammatory disease. Deficiencies may include global deficiencies in Treg numbers or function, subtle 'holes in the Treg repertoire' in tissue-resident Treg populations, or simply Treg insufficiencies that are unable to counter an overwhelming molecular mimicry stimulus. Tolerogenic vaccination and Treg-based immunotherapy are two therapeutic modalities meant to restore dominance of Treg networks to reverse chronic inflammatory disease. Studies of these therapeutic modalities in a preclinical setting have provided insight into the Treg niche, including the concept that intermediate-efficiency TCR signaling, high IFN-beta concentrations, and low IL-2 concentrations favor Treg responses and active dominant mechanisms of immune tolerance. Overall, the purpose here is to assimilate new and established concepts regarding how cognate TCR specificity of the Treg repertoire and the contingent cytokine networks provide a foundation for understanding Treg suppressive strategy.
引用
收藏
页数:17
相关论文
共 50 条
  • [41] Functional characterization of FoxP3+regulatory T cells in Chronic Obstructive Pulmonary Disease
    Talwar, Anjana
    Sampath, Meghashree
    Bade, Geetanjali
    Guleria, Randeep
    Sen, Sudip
    Mohan, Anant
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [42] Role of Tiam1 in finetuning intestinal Foxp3+regulatory T cells
    Herppich, Susanne
    Hoenicke, Lisa
    Smout, Justine
    Kruse, Friederike
    Niemz, Jana
    Grewelin-Pils, Marina C.
    Chu, Xiaojing
    Zhang, Bowen
    Li, Yang
    Huehn, Jochen
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1509 - 1509
  • [43] Expression of GARP selectively identifies activated human FOXP3+regulatory T cells
    Wang, Rui
    Kozhaya, Lina
    Mercer, Frances
    Khaitan, Alka
    Fujii, Hodaka
    Unutmaz, Derya
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (32) : 13439 - 13444
  • [44] Adipose tissue macrophages induce PPARγ- high FOXP3+regulatory T cells
    Onodera, Toshiharu
    Fukuhara, Atsunori
    Jang, Myoung Ho
    Shin, Jihoon
    Aoi, Keita
    Kikuta, Junichi
    Otsuki, Michio
    Ishii, Masaru
    Shimomura, Iichiro
    SCIENTIFIC REPORTS, 2015, 5
  • [45] Foxp3+regulatory T cells control inflammation in the murine model of atopic dermatitis
    Lehtimaki, Sari
    Lauerma, Antti
    Wolff, Henrik
    Alenius, Harri
    Fyhrquist, Nanna
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 : S37 - S37
  • [46] FOXP3+Regulatory T-Cells Are Associated with Acute Rejection in Lung Transplants
    Pecl, J.
    Aubry, M. C.
    Jenkins, S. M.
    Scott, J. P.
    Cassivi, S. D.
    Roden, A. C.
    LABORATORY INVESTIGATION, 2012, 92 : 486A - 486A
  • [47] SELECTIVE DEPLETION OF FOXP3+REGULATORY T CELLS EXACERBATES EXPERIMENTAL ATHEROSCLEROSIS IN MICE
    Gerdes, N.
    Klingenberg, R.
    Strodthoff, D.
    Sparwasser, T.
    Lahl, K.
    Hansson, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [48] Foxp3+regulatory T-cells during the first year of preseasonal immunotherapy
    Ozdemir, Kepil S.
    Guloglu, D.
    Sin, B.
    Ikinciogullari, A.
    Misirligil, Z.
    ALLERGY, 2012, 67 : 126 - 126
  • [49] Downregulation of TIGIT Expression in FOXP3+Regulatory T Cells in Acute Coronary Syndrome
    Xiong, Xinlin
    Luo, Zhenhua
    Zhou, Haiyan
    Duan, Zonggang
    Niu, Li
    Zhang, Kai
    Huang, Guangwei
    Li, Wei
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 1195 - 1207
  • [50] FOXP3+Regulatory T-Cells Are Associated with Acute Rejection in Lung Transplants
    Pecl, J.
    Aubry, M. C.
    Jenkins, S. M.
    Scott, J. P.
    Cassivi, S. D.
    Roden, A. C.
    MODERN PATHOLOGY, 2012, 25 : 486A - 486A